An Investigation into Cell-Free DNA in Different Common Cancers

Diagnosis is the most important step in different diseases, especially in cancers and blood malignancies. There are different methods in order to better diagnose of cancer, but many of them are invasive and also, some of them are not useful for immediate diagnosis. Cell-free DNA (cfDNA) or liquid bi...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Molecular biotechnology Ročník 66; číslo 12; s. 3462 - 3474
Hlavní autori: Nafar, Samira, Hosseini, Kamran, Shokrgozar, Negin, Farahmandi, Amir Yousef, Alamdari-Palangi, Vahab, Saber Sichani, Ali, Fallahi, Jafar
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: New York Springer US 01.12.2024
Springer Nature B.V
Predmet:
Biochemistry
Biological Techniques
Biomarkers
Biomarkers, Tumor - blood
Biomarkers, Tumor - genetics
Biopsy
Biotechnology
Blood
Blood cancer
blood serum
Breast cancer
Breast carcinoma
breast neoplasms
Cancer
Cell Biology
Chemistry
Chemistry and Materials Science
Circulating Tumor DNA - blood
Circulating Tumor DNA - genetics
Deoxyribonucleic acid
Diagnosis
Disease management
DNA
Hepatocellular carcinoma
hepatoma
Human Genetics
Humans
Invasiveness
Liquid Biopsy - methods
Liver cancer
Lung cancer
Lung carcinoma
lung neoplasms
Malignancy
Morbidity
Neoplasms - blood
Neoplasms - diagnosis
Neoplasms - genetics
Peripheral blood
Protein Science
Review Paper
Solid tumors
Tumor cells
Tumors
Cell-free DNA
Biomarker
Cancer
ISSN:1073-6085, 1559-0305, 1559-0305
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Diagnosis is the most important step in different diseases, especially in cancers and blood malignancies. There are different methods in order to better diagnose of cancer, but many of them are invasive and also, some of them are not useful for immediate diagnosis. Cell-free DNA (cfDNA) or liquid biopsy easily accessible in peripheral blood is one of the non-invasive prognostic biomarkers in various areas of cancer management. In fact, amounts of cfDNA in serum or plasma can be used for diagnosis. In this review, we have considered some cancers such as hepatocellular carcinoma, lung cancer, breast cancer, and hematologic malignancies to compare the various methods of cfDNA diagnosis. Highlights The result of early diagnosis along with correct treatment decreases morbidity. Cell-free DNA is a non-invasive way of diagnosing the presence of tumor cells in earlier stages of cancer. DNA released from both solid tumors and hematologic malignancies is usable in this method. Genetic feature of cancer cells at different stages can help in prescribing the amount and type of drugs.
AbstractList Diagnosis is the most important step in different diseases, especially in cancers and blood malignancies. There are different methods in order to better diagnose of cancer, but many of them are invasive and also, some of them are not useful for immediate diagnosis. Cell-free DNA (cfDNA) or liquid biopsy easily accessible in peripheral blood is one of the non-invasive prognostic biomarkers in various areas of cancer management. In fact, amounts of cfDNA in serum or plasma can be used for diagnosis. In this review, we have considered some cancers such as hepatocellular carcinoma, lung cancer, breast cancer, and hematologic malignancies to compare the various methods of cfDNA diagnosis.
Diagnosis is the most important step in different diseases, especially in cancers and blood malignancies. There are different methods in order to better diagnose of cancer, but many of them are invasive and also, some of them are not useful for immediate diagnosis. Cell-free DNA (cfDNA) or liquid biopsy easily accessible in peripheral blood is one of the non-invasive prognostic biomarkers in various areas of cancer management. In fact, amounts of cfDNA in serum or plasma can be used for diagnosis. In this review, we have considered some cancers such as hepatocellular carcinoma, lung cancer, breast cancer, and hematologic malignancies to compare the various methods of cfDNA diagnosis.Diagnosis is the most important step in different diseases, especially in cancers and blood malignancies. There are different methods in order to better diagnose of cancer, but many of them are invasive and also, some of them are not useful for immediate diagnosis. Cell-free DNA (cfDNA) or liquid biopsy easily accessible in peripheral blood is one of the non-invasive prognostic biomarkers in various areas of cancer management. In fact, amounts of cfDNA in serum or plasma can be used for diagnosis. In this review, we have considered some cancers such as hepatocellular carcinoma, lung cancer, breast cancer, and hematologic malignancies to compare the various methods of cfDNA diagnosis.
Diagnosis is the most important step in different diseases, especially in cancers and blood malignancies. There are different methods in order to better diagnose of cancer, but many of them are invasive and also, some of them are not useful for immediate diagnosis. Cell-free DNA (cfDNA) or liquid biopsy easily accessible in peripheral blood is one of the non-invasive prognostic biomarkers in various areas of cancer management. In fact, amounts of cfDNA in serum or plasma can be used for diagnosis. In this review, we have considered some cancers such as hepatocellular carcinoma, lung cancer, breast cancer, and hematologic malignancies to compare the various methods of cfDNA diagnosis.HighlightsThe result of early diagnosis along with correct treatment decreases morbidity.Cell-free DNA is a non-invasive way of diagnosing the presence of tumor cells in earlier stages of cancer.DNA released from both solid tumors and hematologic malignancies is usable in this method.Genetic feature of cancer cells at different stages can help in prescribing the amount and type of drugs.
Diagnosis is the most important step in different diseases, especially in cancers and blood malignancies. There are different methods in order to better diagnose of cancer, but many of them are invasive and also, some of them are not useful for immediate diagnosis. Cell-free DNA (cfDNA) or liquid biopsy easily accessible in peripheral blood is one of the non-invasive prognostic biomarkers in various areas of cancer management. In fact, amounts of cfDNA in serum or plasma can be used for diagnosis. In this review, we have considered some cancers such as hepatocellular carcinoma, lung cancer, breast cancer, and hematologic malignancies to compare the various methods of cfDNA diagnosis. Highlights The result of early diagnosis along with correct treatment decreases morbidity. Cell-free DNA is a non-invasive way of diagnosing the presence of tumor cells in earlier stages of cancer. DNA released from both solid tumors and hematologic malignancies is usable in this method. Genetic feature of cancer cells at different stages can help in prescribing the amount and type of drugs.
Author Farahmandi, Amir Yousef
Alamdari-Palangi, Vahab
Fallahi, Jafar
Hosseini, Kamran
Shokrgozar, Negin
Nafar, Samira
Saber Sichani, Ali
Author_xml – sequence: 1
  givenname: Samira
  surname: Nafar
  fullname: Nafar, Samira
  organization: Medical Genetic Department, Shiraz University of Medical Science
– sequence: 2
  givenname: Kamran
  surname: Hosseini
  fullname: Hosseini, Kamran
  organization: Department of Molecular Medicine, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences
– sequence: 3
  givenname: Negin
  surname: Shokrgozar
  fullname: Shokrgozar, Negin
  organization: Hematology Research Center, Shiraz University of Medical Science
– sequence: 4
  givenname: Amir Yousef
  surname: Farahmandi
  fullname: Farahmandi, Amir Yousef
  organization: Department of English, Shiraz University of Medical Sciences
– sequence: 5
  givenname: Vahab
  surname: Alamdari-Palangi
  fullname: Alamdari-Palangi, Vahab
  organization: Department of Molecular Medicine, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences
– sequence: 6
  givenname: Ali
  surname: Saber Sichani
  fullname: Saber Sichani, Ali
  organization: Department of Biology, Texas A&M University
– sequence: 7
  givenname: Jafar
  orcidid: 0000-0002-8485-9247
  surname: Fallahi
  fullname: Fallahi, Jafar
  email: jafarf80@gmail.com
  organization: Department of Molecular Medicine, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38071680$$D View this record in MEDLINE/PubMed
BookMark eNqFkU1LAzEQhoNU7If-AQ-y4MXL6iTZj-QkZWtVKHrRc8hms2XLbrYmW8F_b9ptEXqohzBheN7hnXnHaGBaoxG6xnCPAdIHhwlQGgLxD3iahPwMjXAc8xAoxAP_h5SGCbB4iMbOrQAIjiN6gYaUQYoTBiP0ODXBq_nWrquWsqtaE1Sma4NM13U4t1oHs7epbwWzqiy11aYLsrZpPJZJo7R1l-i8lLXTV_s6QZ_zp4_sJVy8P79m00WoImBdyLiKckkYy7EsOC_TmOfAqEpznnKZMyhYwqQqpI4iTXkuQfqe91iAVMA4naC7fu7atl8bb1c0lVPepTS63ThB_WY4SWj6P0o4EB5zQrfo7RG6ajfW-EX8QMKiiEUMPHWzpzZ5owuxtlUj7Y84XNEDrAeUbZ2zuhSq6nbX7KysaoFBbAMTfWDCByZ2gYmtA3IkPUw_KaK9yHnYLLX9s31C9QtzEqRc
CitedBy_id crossref_primary_10_1159_000541173
crossref_primary_10_3390_cancers17142366
Cites_doi 10.1073/pnas.1511694112
10.1002/jmri.10176
10.1093/annonc/mdy080
10.1016/j.jmoldx.2021.05.001
10.1111/bjh.13842
10.1186/s13045-016-0379-6
10.1038/s41598-022-16685-3
10.2147/JBM.S230842
10.1016/j.ejca.2017.10.029
10.5045/br.2019.54.2.114
10.14715/cmb/2019.65.6.11
10.1182/blood-2002-01-0099
10.1016/j.cca.2013.05.022
10.1016/j.mrrev.2019.05.002
10.7150/ijbs.44024
10.1016/j.ijpara.2014.08.004
10.12688/f1000research.9022.1
10.1373/clinchem.2018.297549
10.1016/j.ijid.2017.12.002
10.1080/10428194.2018.1492123
10.1182/blood-2015-11-624288
10.1242/dmm.036863
10.1016/S0140-6736(12)60605-9
10.1158/1078-0432.CCR-22-1654
10.3324/haematol.2018.189159
10.1080/15384047.2019.1598759
10.21037/atm.2018.12.57
10.1001/jamaoncol.2020.2592
10.1016/j.oraloncology.2021.105254
10.3389/fonc.2022.870487
10.1016/j.csbj.2018.10.002
10.17219/acem/84935
10.18632/oncotarget.17384
10.1038/s41571-019-0187-3
10.1182/bloodadvances.2020003039
10.1155/2019/7954921
10.20517/2394-5079.2018.108
10.1016/j.medj.2021.09.002
10.4155/fsoa-2017-0140
10.1038/s41467-021-24994-w
10.1093/abbs/gmy104
10.1182/blood-2017-11-812073
10.1186/s13058-016-0788-z
10.1007/s10549-010-0747-9
10.1038/s41375-021-01492-y
10.1007/s00277-018-3529-9
10.1038/ncomms15086
10.1186/s12967-019-2079-9
10.3390/cancers14071783
10.1038/s41586-019-1272-6
10.1182/blood-2014-05-577189
10.1038/s41576-018-0071-5
10.1007/978-1-4020-6784-6
10.1016/j.canep.2018.06.003
10.47102/annals-acadmedsg.V35N4p242
10.1038/s41392-020-0133-y
10.7150/jca.10747
10.3349/ymj.2018.59.4.470
10.3233/BLC-170140
10.7150/jca.27615
10.24953/turkjped.2020.04.003
10.1371/journal.pgen.1006162
10.1186/s13148-020-00979-2
10.3389/fcell.2021.639233
10.3892/or.2013.2906
10.1182/bloodadvances.2017015164
10.1093/annonc/mdw400
10.1111/1759-7714.13002
10.18632/oncotarget.14390
10.1038/nrc1299
10.1016/j.trsl.2018.07.001
10.1016/j.amjms.2018.10.006
10.1007/s11899-016-0328-z
10.1002/0471142905.hg0908s07
10.1158/1078-0432.CCR-13-2933
10.2991/jegh.k.191008.001
10.1038/modpathol.2016.92
10.7150/jca.15618
10.1007/s13402-018-0413-5
10.1056/NEJMoa1213261
10.1038/nrc1041
10.3390/ijms19041007
10.1016/j.xinn.2022.100259
10.1155/2012/756353
10.1158/1078-0432.CCR-19-0624
10.1038/s41467-018-04001-5
10.1126/scitranslmed.aan2415
10.1002/ajh.24402
10.1093/annonc/mdv498
10.1158/0008-5472.CAN-18-1082
10.3389/fonc.2022.852573
10.1016/j.annonc.2020.11.007
10.1093/annonc/mdp006
10.4143/crt.2016.089
10.1186/s12916-021-02182-3
10.1016/j.ceb.2004.09.002
10.2217/pme-2020-0019
10.1016/j.mayocp.2015.04.025
10.1182/blood-2016-03-635219
10.1016/S0140-6736(16)32407-2
10.1016/j.oooo.2021.01.027
10.1021/acs.chemrev.5b00321
10.1016/j.annonc.2019.11.014
10.1007/s10549-021-06142-6
10.1016/j.cancergen.2018.02.005
10.1111/ejh.13541
10.1007/s00277-022-04771-5
10.1093/annonc/mdv304
10.1080/14737140.2019.1548938
10.1093/annonc/mdx096
10.1186/1476-4598-8-105
10.1002/rth2.12557
10.1016/j.jiac.2021.12.007
ContentType Journal Article
Copyright The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Copyright_xml – notice: The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
– notice: 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QL
7QO
7T7
7U9
7X7
7XB
88A
88E
88I
8AO
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABJCF
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
L6V
LK8
M0S
M1P
M2P
M7N
M7P
M7S
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PTHSS
Q9U
7X8
7S9
L.6
DOI 10.1007/s12033-023-00976-9
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest One Sustainability (subscription)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
Biological Science Collection
ProQuest Central
Technology collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Engineering Collection
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Science Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Engineering Database
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
Engineering collection
ProQuest Central Basic
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
ProQuest Central Essentials
SciTech Premium Collection
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Engineering Database
Virology and AIDS Abstracts
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest Health & Medical Research Collection
ProQuest Engineering Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
ProQuest Central Basic
ProQuest Science Journals
ProQuest SciTech Collection
ProQuest Medical Library
Materials Science & Engineering Collection
ProQuest Central (Alumni)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList AGRICOLA
MEDLINE - Academic
MEDLINE
ProQuest Central Student
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Engineering
Chemistry
Biology
EISSN 1559-0305
EndPage 3474
ExternalDocumentID 38071680
10_1007_s12033_023_00976_9
Genre Journal Article
Review
GroupedDBID ---
-Y2
.86
.VR
06C
06D
0R~
0VY
123
1N0
2.D
203
28-
29M
2J2
2JN
2JY
2KG
2KM
2LR
2VQ
2~H
30V
3SX
4.4
406
408
40D
40E
53G
5VS
67N
6NX
7X7
88E
88I
8AO
8FE
8FG
8FH
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
A8Z
AAAVM
AABHQ
AACDK
AAHBH
AAHNG
AAIAL
AAIKT
AAJBT
AAJKR
AANXM
AANZL
AAPKM
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBRH
ABDBE
ABDZT
ABECU
ABFSG
ABFTV
ABHLI
ABHQN
ABJCF
ABJNI
ABJOX
ABKCH
ABMNI
ABMQK
ABNWP
ABQBU
ABQSL
ABRTQ
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACCUX
ACDTI
ACGFS
ACGOD
ACHSB
ACHXU
ACIWK
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACSTC
ACZOJ
ADBBV
ADHHG
ADHIR
ADHKG
ADKNI
ADKPE
ADMLS
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEUYN
AEVLU
AEXYK
AEZWR
AFBBN
AFDZB
AFEXP
AFGCZ
AFHIU
AFKRA
AFLOW
AFOHR
AFQWF
AFRAH
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGQPQ
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHMBA
AHPBZ
AHSBF
AHWEU
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AIXLP
AJBLW
AJRNO
AJZVZ
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
ATHPR
AVWKF
AXYYD
AYFIA
AYJHY
AZFZN
AZQEC
B-.
BA0
BBNVY
BBWZM
BDATZ
BENPR
BGLVJ
BGNMA
BHPHI
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DNIVK
DPUIP
DU5
DWQXO
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNUQQ
GNWQR
GQ7
H13
HCIFZ
HF~
HG6
HMCUK
HMJXF
HRMNR
HVGLF
HZ~
I-F
IJ-
IKXTQ
ITM
IWAJR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JZLTJ
KOV
L6V
LK8
LLZTM
M1P
M2P
M4Y
M7P
M7S
MA-
ML0
N2Q
NB0
NDZJH
NF0
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OVD
P19
P2P
PF0
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
PT4
PT5
PTHSS
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RIG
RNI
ROL
RPX
RSV
RZK
S16
S1Z
S26
S27
S28
S3A
S3B
SAP
SBL
SCG
SCLPG
SDH
SDM
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
STPWE
SV3
SZN
T13
T16
TEORI
TSG
TSV
TUC
TUS
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W48
WK6
WK8
YLTOR
ZMTXR
~EX
~KM
AAYXX
AFFHD
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QL
7QO
7T7
7U9
7XB
88A
8FD
8FK
C1K
FR3
H94
K9.
M7N
P64
PKEHL
PQEST
PQUKI
Q9U
7X8
7S9
L.6
ID FETCH-LOGICAL-c408t-89c4ba288b1ad99f759b083c7b979ab80d868acdae44e39ba0a80d716d0ac0893
IEDL.DBID RSV
ISICitedReferencesCount 3
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001118092300001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1073-6085
1559-0305
IngestDate Fri Sep 05 06:47:38 EDT 2025
Sun Nov 09 11:45:43 EST 2025
Tue Dec 02 10:00:51 EST 2025
Mon Jul 21 06:07:37 EDT 2025
Sat Nov 29 06:18:00 EST 2025
Tue Nov 18 22:32:59 EST 2025
Mon Jul 21 06:23:03 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords Cell-free DNA
Biomarker
Cancer
Language English
License 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c408t-89c4ba288b1ad99f759b083c7b979ab80d868acdae44e39ba0a80d716d0ac0893
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0002-8485-9247
PMID 38071680
PQID 3128448480
PQPubID 55363
PageCount 13
ParticipantIDs proquest_miscellaneous_3154166379
proquest_miscellaneous_2902959239
proquest_journals_3128448480
pubmed_primary_38071680
crossref_citationtrail_10_1007_s12033_023_00976_9
crossref_primary_10_1007_s12033_023_00976_9
springer_journals_10_1007_s12033_023_00976_9
PublicationCentury 2000
PublicationDate 20241200
2024-12-00
2024-Dec
20241201
PublicationDateYYYYMMDD 2024-12-01
PublicationDate_xml – month: 12
  year: 2024
  text: 20241200
PublicationDecade 2020
PublicationPlace New York
PublicationPlace_xml – name: New York
– name: Switzerland
– name: Totowa
PublicationTitle Molecular biotechnology
PublicationTitleAbbrev Mol Biotechnol
PublicationTitleAlternate Mol Biotechnol
PublicationYear 2024
Publisher Springer US
Springer Nature B.V
Publisher_xml – name: Springer US
– name: Springer Nature B.V
References LittleSAmplification-refractory mutation system (ARMS) analysis of point mutationsCurrent Protocols in Human Genetics.1995719.8.19.8.12
E F, T K, G T. Serum Expression of seven MicroRNAs in chronic lymphocytic leukemia patients. J Blood Med. 2020;11(1):97–102.
BunzFPrinciples of cancer genetics2008BerlinSpringer
ZhangYXuYZhongWZhaoJChenMZhangLTotal DNA input is a crucial determinant of the sensitivity of plasma cell-free DNA EGFR mutation detection using droplet digital PCROncotarget2017845861587328052016
de la Cruz-MerinoLLejeuneMNogales FernándezEHenao CarrascoFGrueso LópezAIllescasVacasARole of immune escape mechanisms in Hodgkin's lymphoma development and progression: A whole new world with therapeutic implicationsClinical and Developmental Immunology.20122012124
RossiDDiopFSpaccarotellaEMontiSZanniMRasiSDiffuse large B-cell lymphoma genotyping on the liquid biopsyBlood, The Journal of the American Society of Hematology.201712914194719571:CAS:528:DC%2BC2sXhtV2jur%2FK
OhC-MWonY-JJungK-WKongH-JChoHLeeJ-KCancer statistics in Korea: Incidence, mortality, survival, and prevalence in 2013Cancer Research and Treatment2016482436269873954843732
Delfau-LarueM-Hvan Der GuchtADupuisJJaisJ-PNelIBeldi-FerchiouATotal metabolic tumor volume, circulating tumor cells, cell-free DNA: Distinct prognostic value in follicular lymphomaBlood Advances.2018278078161:CAS:528:DC%2BC1MXlvVKmsrc%3D296363265894260
MoreauPSan MiguelJSonneveldPMateosM-VZamagniEAvet-LoiseauHMultiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology.201728Suppl_4iv52iv611:STN:280:DC%2BC1crit1amuw%3D%3D28453614
RakhitCPTriggRMLe QuesneJKellyMShawJAPritchardCEarly detection of pre-malignant lesions in a KRASG12D-driven mouse lung cancer model by monitoring circulating free DNADisease Models and Mechanisms.2019122dmm0368631:CAS:528:DC%2BC1MXhs1yksbrF307604956398498
KohlerCRadpourRBarekatiZAsadollahiRBitzerJWightELevels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumorsMolecular Cancer.200981105199226042780981
HeitzerEHaqueISRobertsCESpeicherMRCurrent and future perspectives of liquid biopsies in genomics-driven oncologyNature Reviews Genetics.201920271881:CAS:528:DC%2BC1cXitFersbrF30410101
MossJZickAGrinshpunACarmonEMaozMOchanaBCirculating breast-derived DNA allows universal detection and monitoring of localized breast cancerAnnals of Oncology.20203133954031:CAS:528:DC%2BB3MXislGnsb7K32067681
YalçınBKutlukTAğbabaSKDemirÇTalimBCirculating Epstein-Barr virus DNA and cell-free DNA in pediatric lymphomasTurkish Journal of Pediatrics.202062454132779406
JordanCTCancer stem cell biology: From leukemia to solid tumorsCurrent Opinion in Cell Biology.20041667087121:CAS:528:DC%2BD2cXpsVOruro%3D15530785
SuY-HKimAKJainSLiquid biopsies for hepatocellular carcinomaTranslational Research.201820184300560686483086
KahlBSYangDTFollicular lymphoma: Evolving therapeutic strategiesBlood201612717205520631:CAS:528:DC%2BC28Xhs1ent7%2FM26989204
PhallenJLealAWoodwardBDFordePMNaidooJMarroneKAEarly noninvasive detection of response to targeted therapy in non-small cell lung cancerCancer Research.2019796120412131:CAS:528:DC%2BC1MXhtFGhurfE30573519
JungMEllingerJGevenslebenHSyringILudersCde VosLCell-free SHOX2 DNA methylation in blood as a molecular staging parameter for risk stratification in renal cell carcinoma patients: a prospective observational cohort studyClinical Chemistry20196545595681:CAS:528:DC%2BC1MXht1aiu7zF30626634
KhierSLohanLKinetics of circulating cell-free DNA for biomedical applications: Critical appraisal of the literatureFuture Science OA.201844FSO2951:CAS:528:DC%2BC1cXntlegt7w%3D296823275905581
HohausSGiacheliaMMassiniGMansuetoGVannataBBozzoliVCell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomasAnnals of Oncology.2009208140814131:STN:280:DC%2BD1MrjtlKksQ%3D%3D19465421
YangZQiWSunLZhouHZhouBHuYDNA methylation analysis of selected genes for the detection of early-stage lung cancer using circulating cell-free DNAAdvances in Clinical and Experimental Medicine201928335536030516882
RoschewskiMStaudtLMWilsonWHDynamic monitoring of circulating tumor DNA in non-Hodgkin lymphomaBlood201612725312731321:CAS:528:DC%2BC28Xhs1entL%2FP270810974920019
PhallenJSausenMAdleffVLealAHrubanCWhiteJDirect detection of early-stage cancers using circulating tumor DNAScience Translational Medicine201792415
MagbanuaMJMSwigartLBWuH-THirstGLYauCWolfDMCirculating tumor DNA in neoadjuvant-treated breast cancer reflects response and survivalAnnals of Oncology.20213222292391:CAS:528:DC%2BB38XhvVKrtbs%3D33232761
HeGChenYZhuCZhouJXieXFeiRApplication of plasma circulating cell-free DNA detection to the molecular diagnosis of hepatocellular carcinomaAmerican Journal of Translational Research.201911314281:CAS:528:DC%2BC1MXisVSit7nI309721726456549
WangYSpringerSZhangMMcMahonKWKindeIDobbynLDetection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cordProceedings of the National academy of Sciences of the United States of America201511231970497091:CAS:528:DC%2BC2MXhtF2hsrbM261957504534284
DilliottAAFarhanSMGhaniMSatoCLiangEZhangMTargeted next-generation sequencing and bioinformatics pipeline to evaluate genetic determinants of constitutional diseaseJoVE (Journal of Visualized Experiments).2018134
CristianoSLealAPhallenJFikselJAdleffVBruhmDCGenome-wide cell-free DNA fragmentation in patients with cancerNature20195701
LissaDRoblesAIComprehensive genomic analysis of circulating tumor DNA for patients with advanced non-small cell lung cancerAnnals of Translational Medicine.201975801:CAS:528:DC%2BB3cXhsVequ7g%3D310199306462649
MackEKHartmannSRossPWollmerEMannCNeubauerAMonitoring multiple myeloma in the peripheral blood based on cell-free DNA and circulating plasma cellsAnnals of Hematology.202210148118241:CAS:528:DC%2BB38Xos1ajtrk%3D351066398913458
EichenauerDAlemanBAndréMFedericoMHutchingsMIllidgeTHodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology.201829iv191:STN:280:DC%2BC1MfmslKisA%3D%3D29796651
UnderhillHRKitzmanJOHellwigSWelkerNCDazaRBakerDNFragment length of circulating tumor DNAPLoS Genetics.2016127274280494948782
SobeskySMammadovaLCirilloMDreesEEMattlenerJDörrHIn-depth cell-free DNA sequencing reveals genomic landscape of Hodgkin’s lymphoma and facilitates ultrasensitive residual disease detectionMedicine2021210117193.e111:CAS:528:DC%2BB38XhvVGks7rJ
Guerriero P, Moshiri F, Lupini L, Sabbioni S, Negrini M, Callegari E. Circulating tumor DNAs and non-coding RNAs as potential biomarkers for hepatocellular carcinoma diagnosis, prognosis and response to therapy. Hepatoma Research. 2019.
LeonSShapiroBSklaroffDYarosMFree DNA in the serum of cancer patients and the effect of therapyCancer Research.19773736466501:CAS:528:DyaE2sXhtFyqsLc%3D837366
Alunni-FabbroniMRönschKHuberTCyranCCSeidenstickerMMayerleJCirculating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: A translational exploratory study from the SORAMIC trialJournal of Translational Medicine.20191711151:CAS:528:DC%2BC1MXhvVyjsrjP
BennDKVigPSEstimation of x-ray radiation related cancers in US dental offices: Is it worth the risk?Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology.2021132559760833741287
LiCHeQLiangHHeJLiangW41P Diagnostic accuracy of droplet digital PCR (ddPCR) and amplification refractory mutation system PCR (ARMS-PCR) for detecting EGFR mutation in cell-free DNA of advanced lung cancer: A meta-analysisAnnals of Oncology.201930Supplement 2mdz073.20
Dowler NygaardASpindlerK-LGPallisgaardNAndersenRFJakobsenALevels of cell-free DNA and plasma KRAS during treatment of advanced NSCLCOncology Reports.201431296997424316734
WangY-FWangX-JLuZLiuS-RJiangYWanX-QOverexpression of Stat3 increases circulating cfDNA in breast cancerBreast Cancer Research and Treatment.202118769801:CAS:528:DC%2BB3MXls1Ogs7o%3D33630196
LeighlNBPageRDRaymondVMDanielDBDiversSGReckampKLClinical utility of comprehensive cell-free DNA analysis to identify genomic biomarkers in patients with newly diagnosed metastatic non-small cell lung cancerClinical Cancer Research.2019251546911:CAS:528:DC%2BB3cXhs1Chsb3I30988079
MiaoYFanYZhangLMaTLiRClinical value of plasma cfDNA concentration and integrity in breast cancer patientsCellular and Molecular Biology.2019656647231472049
TillyHGomes da SilvaMVitoloUJackAMeignanMLopez-GuillermoADiffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology.201526Suppl 5v116v12526314773
LissaDRoblesAIComprehensive genomic analysis of circulating tumor DNA for patients with advanced non-small cell lung cancerAnn Transl Med.201975801:CAS:528:DC%2BB3cXhsVequ7g%3D310199306462649
ZhangYLiMGaoXChenYLiuTNanotechnology in cancer diagnosis: Progress, challenges and opportunitiesJournal of Hematology and Oncology.2019121113
PezzutoFBuonaguroLBuonaguroFTorneselloMThe role of circulating free DNA and microRNA in non-invasive diagnosis of HBV-and HCV-related hepatocellular carcinomaInternational Journal of Molecular Sciences.20181941007295972595979406
GaoQZengQWangZLiCXuYCuiPCirculating cell-free DNA for cancer early detectionThe Innovation.2022341002591:CAS:528:DC%2BB38XitVemtL3I356475729133648
McKayPFieldingPGallop-EvansEHallGWLambertJLeachMGuidelines for the investigation and management of nodular lymphocyte predominant Hodgkin lymphomaBritish Journal of Haematology.20161721324326538004
TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA: A Cancer Journal For Clinicians.20156528710825651787
Fernández-MirandaIPedrosaLLlanosMFrancoFFGómezSMartín-AcostaPMonitoring of circulating tumor DNA predicts response to treatment and early progression in follicular lymphoma: Results of a prospective pilot studyClinical Cancer Research.20232920936269794
ChinenABGuanCMFerrerJRBarnabySNMerkelTJMirkinCANanoparticle probes for the detection of cancer biomarkers, cells,
Q Gao (976_CR20) 2022; 3
NB Leighl (976_CR58) 2019; 25
J Caers (976_CR75) 2018; 103
M Eskandari (976_CR103) 2019; 54
Y-Y Yan (976_CR14) 2021; 9
Y-F Wang (976_CR121) 2021; 187
R Esposito Abate (976_CR55) 2019; 19
PA Futreal (976_CR24) 2004; 4
S Park (976_CR21) 2018; 59
P Mandel (976_CR25) 1948; 142
D Lissa (976_CR54) 2019; 7
A Kustanovich (976_CR26) 2019; 20
S Ren (976_CR62) 2021; 18
LH Sehn (976_CR100) 2015; 125
Y-H Su (976_CR45) 2018; 201
M Alunni-Fabbroni (976_CR51) 2019; 17
Z Yang (976_CR65) 2019; 28
I Fernández-Miranda (976_CR109) 2023; 29
J Phallen (976_CR57) 2019; 79
976_CR124
BT Li (976_CR126) 2016; 27
976_CR47
EK Mack (976_CR82) 2022; 101
T Todenhöfer (976_CR36) 2018; 4
HR Underhill (976_CR27) 2016; 12
X Wu (976_CR17) 2020; 16
SV Rajkumar (976_CR76) 2016; 91
A Huang (976_CR50) 2016; 7
S Deshpande (976_CR83) 2021; 106
P Moreau (976_CR77) 2017; 28
R Kumar (976_CR73) 2021; 5
P McKay (976_CR92) 2016; 172
J Liu (976_CR120) 2021; 20
K Pantel (976_CR15) 2019; 16
LA Torre (976_CR2) 2015; 65
S Sobesky (976_CR97) 2021; 2
LG Tan (976_CR12) 2006; 35
BS Kahl (976_CR106) 2016; 127
M Jung (976_CR22) 2019; 65
S Cristiano (976_CR53) 2019; 570
C Kohler (976_CR112) 2009; 8
M Dreyling (976_CR107) 2016; 27
CT Jordan (976_CR5) 2004; 16
L Cabel (976_CR42) 2018
F Bunz (976_CR1) 2008
S Leon (976_CR18) 1977; 37
L Bessi (976_CR90) 2019; 60
BF Skinnider (976_CR87) 2002; 99
DK Benn (976_CR4) 2021; 132
S El Messaoudi (976_CR68) 2013; 424
L Buedts (976_CR98) 2021; 5
A Dowler Nygaard (976_CR123) 2014; 31
L Yan (976_CR41) 2018; 67
K Cervena (976_CR43) 2019; 781
H Yu (976_CR60) 2019; 357
H Tilly (976_CR101) 2015; 26
J Shao (976_CR72) 2022; 12
B Ilhan (976_CR8) 2021; 116
D Mathios (976_CR64) 2021; 12
M-H Delfau-Larue (976_CR108) 2018; 2
YV Teo (976_CR23) 2019; 18
JA Beaver (976_CR116) 2014; 20
S Valpione (976_CR31) 2018; 88
C Li (976_CR61) 2019; 30
Y Wang (976_CR29) 2015; 112
BT Li (976_CR59) 2016; 76
R Etzioni (976_CR7) 2003; 3
D Eichenauer (976_CR88) 2018; 29
MJM Magbanua (976_CR118) 2021; 32
L Shi (976_CR69) 2022; 28
Z Niu (976_CR33) 2018; 50
D Attali (976_CR37) 2016; 5
S Li (976_CR117) 2019; 10
S Khier (976_CR30) 2018; 4
KR Shankland (976_CR91) 2012; 380
Y Zhang (976_CR9) 2019; 12
C-M Oh (976_CR66) 2016; 48
JO Armitage (976_CR84) 2017; 390
J Phallen (976_CR19) 2017; 9
Y Miao (976_CR122) 2019; 65
M Roschewski (976_CR95) 2016; 127
R Yang (976_CR38) 2014; 44
S Little (976_CR40) 1995; 7
F Pezzuto (976_CR44) 2018; 19
976_CR81
L de la Cruz-Merino (976_CR86) 2012; 2012
D Lissa (976_CR34) 2019; 7
L Zhong (976_CR70) 2018; 16
B Luo (976_CR48) 2022; 20
A Barata (976_CR67) 2016; 11
T Hatipoğlu (976_CR110) 2022; 12
C Mattiuzzi (976_CR3) 2019; 9
RE Board (976_CR115) 2010; 120
V Spina (976_CR89) 2018; 131
P Sun (976_CR96) 2019; 10
S Hohaus (976_CR94) 2009; 20
M Elazezy (976_CR35) 2018; 16
976_CR93
D Rossi (976_CR105) 2017; 129
AA Dilliott (976_CR39) 2018; 134
CM Stewart (976_CR32) 2018; 228
G He (976_CR49) 2019; 11
H-Y Chen (976_CR104) 2021; 13
H Xu (976_CR46) 2015; 6
J Moss (976_CR119) 2020; 31
M Macías (976_CR56) 2019; 2019
O Kis (976_CR78) 2017; 8
N Uehiro (976_CR113) 2016; 18
S-J Dawson (976_CR114) 2013; 368
CP Rakhit (976_CR52) 2019; 12
R Sun (976_CR85) 2016; 29
SN Koole (976_CR63) 2022; 14
F-T Wu (976_CR102) 2019; 98
C Rausch (976_CR71) 2021; 23
J Cheng (976_CR111) 2017; 8
E Heitzer (976_CR16) 2019; 20
B Yalçın (976_CR99) 2020; 62
AR Padhani (976_CR10) 2002; 16
Y Zhang (976_CR125) 2017; 8
JM Waldschmidt (976_CR80) 2022; 36
A Patel (976_CR6) 2020; 6
AB Chinen (976_CR11) 2015; 115
W Huang (976_CR13) 2020; 5
H Fettke (976_CR28) 2019; 42
C-H Tang (976_CR74) 2018; 55
S Manier (976_CR79) 2018; 9
References_xml – reference: LiBTDrilonAJohnsonMLHsuMSimaCSMcGinnCA prospective study of total plasma cell-free DNA as a predictive biomarker for response to systemic therapy in patients with advanced non-small-cell lung cancersAnnals of Oncology20162711541591:STN:280:DC%2BC28zjvVSltQ%3D%3D26487589
– reference: MossJZickAGrinshpunACarmonEMaozMOchanaBCirculating breast-derived DNA allows universal detection and monitoring of localized breast cancerAnnals of Oncology.20203133954031:CAS:528:DC%2BB3MXislGnsb7K32067681
– reference: WangY-FWangX-JLuZLiuS-RJiangYWanX-QOverexpression of Stat3 increases circulating cfDNA in breast cancerBreast Cancer Research and Treatment.202118769801:CAS:528:DC%2BB3MXls1Ogs7o%3D33630196
– reference: MacíasMAlegreEAlkorta-AranburuGPatiño-GarcíaAMateosBAnduezaMPThe dynamic use of EGFR mutation analysis in cell-free DNA as a follow-up biomarker during different treatment lines in non-small-cell lung cancer patientsDisease Markers.2019201917
– reference: KahlBSYangDTFollicular lymphoma: Evolving therapeutic strategiesBlood201612717205520631:CAS:528:DC%2BC28Xhs1ent7%2FM26989204
– reference: RakhitCPTriggRMLe QuesneJKellyMShawJAPritchardCEarly detection of pre-malignant lesions in a KRASG12D-driven mouse lung cancer model by monitoring circulating free DNADisease Models and Mechanisms.2019122dmm0368631:CAS:528:DC%2BC1MXhs1yksbrF307604956398498
– reference: MathiosDJohansenJSCristianoSMedinaJEPhallenJLarsenKRDetection and characterization of lung cancer using cell-free DNA fragmentomesNature Communications.202112150601:CAS:528:DC%2BB3MXhvVGns7bK344174548379179
– reference: YalçınBKutlukTAğbabaSKDemirÇTalimBCirculating Epstein-Barr virus DNA and cell-free DNA in pediatric lymphomasTurkish Journal of Pediatrics.202062454132779406
– reference: JungMEllingerJGevenslebenHSyringILudersCde VosLCell-free SHOX2 DNA methylation in blood as a molecular staging parameter for risk stratification in renal cell carcinoma patients: a prospective observational cohort studyClinical Chemistry20196545595681:CAS:528:DC%2BC1MXht1aiu7zF30626634
– reference: ValpioneSGremelGMundraPMiddlehurstPGalvaniEGirottiMRPlasma total cell-free DNA (cfDNA) is a surrogate biomarker for tumour burden and a prognostic biomarker for survival in metastatic melanoma patientsEuropean Journal of Cancer.201888191:CAS:528:DC%2BC2sXhvVeqtLbI291757345769519
– reference: MackEKHartmannSRossPWollmerEMannCNeubauerAMonitoring multiple myeloma in the peripheral blood based on cell-free DNA and circulating plasma cellsAnnals of Hematology.202210148118241:CAS:528:DC%2BB38Xos1ajtrk%3D351066398913458
– reference: Alunni-FabbroniMRönschKHuberTCyranCCSeidenstickerMMayerleJCirculating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: A translational exploratory study from the SORAMIC trialJournal of Translational Medicine.20191711151:CAS:528:DC%2BC1MXhvVyjsrjP
– reference: LissaDRoblesAIComprehensive genomic analysis of circulating tumor DNA for patients with advanced non-small cell lung cancerAnnals of Translational Medicine.201975801:CAS:528:DC%2BB3cXhsVequ7g%3D310199306462649
– reference: TillyHGomes da SilvaMVitoloUJackAMeignanMLopez-GuillermoADiffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology.201526Suppl 5v116v12526314773
– reference: XuHZhuXXuZHuYBoSXingTNon-invasive analysis of genomic copy number variation in patients with hepatocellular carcinoma by next generation DNA sequencingJournal of Cancer.201563247256639424317760
– reference: RajkumarSVMultiple myeloma: 2016 update on diagnosis, risk-stratification, and managementAmerican Journal of Hematology.20169177197341:CAS:528:DC%2BC28XpsFGqsLw%3D272913025291298
– reference: UnderhillHRKitzmanJOHellwigSWelkerNCDazaRBakerDNFragment length of circulating tumor DNAPLoS Genetics.2016127274280494948782
– reference: PadhaniARDynamic contrast-enhanced MRI in clinical oncology: Current status and future directionsJournal of Magnetic Resonance Imaging.200216440742212353256
– reference: ZhongLChenJHuangXLiYJiangTMonitoring immunoglobulin heavy chain and T-cell receptor gene rearrangement in cfDNA as minimal residual disease detection for patients with acute myeloid leukemiaOncology Letters.201816222792288300089306036514
– reference: DilliottAAFarhanSMGhaniMSatoCLiangEZhangMTargeted next-generation sequencing and bioinformatics pipeline to evaluate genetic determinants of constitutional diseaseJoVE (Journal of Visualized Experiments).2018134
– reference: TangC-HLiuH-YHouH-AQiuHHuangK-CSigginsSEpidemiology of multiple myeloma in Taiwan, a population based studyCancer Epidemiology.20185513614129957398
– reference: LiuJZhaoHHuangYXuSZhouYZhangWGenome-wide cell-free DNA methylation analyses improve accuracy of non-invasive diagnostic imaging for early-stage breast cancerMolecular Cancer.202120171:CAS:528:DC%2BB3MXht12ht7bI
– reference: Delfau-LarueM-Hvan Der GuchtADupuisJJaisJ-PNelIBeldi-FerchiouATotal metabolic tumor volume, circulating tumor cells, cell-free DNA: Distinct prognostic value in follicular lymphomaBlood Advances.2018278078161:CAS:528:DC%2BC1MXlvVKmsrc%3D296363265894260
– reference: NiuZTangWLiuTXuPZhuDJiMCell-free DNA derived from cancer cells facilitates tumor malignancy through Toll-like receptor 9 signaling-triggered interleukin-8 secretion in colorectal cancerActa Biochimica et Biophysica Sinica.20185010100710171:CAS:528:DC%2BC1MXhtlWltLzF30239551
– reference: SunPChenCXiaYWangYLiuP-PBiX-WMutation profiling of malignant lymphoma by next-generation sequencing of circulating cell-free DNAJournal of Cancer.20191023231:CAS:528:DC%2BC1MXit1ers7nP307191266360295
– reference: HuangWYanYLiuYLinMMaJZhangWExosomes with low miR-34c-3p expression promote invasion and migration of non-small cell lung cancer by upregulating integrin α2β1Signal Transduction and Targeted Therapy.202051391:CAS:528:DC%2BB3cXnslGltro%3D323176297174429
– reference: EskandariMManoochehrabadiSPashaiefarHZaimyMAAhmadvandMClinical significance of cell-free DNA as a prognostic biomarker in patients with diffuse large B-cell lymphomaBlood Research.20195421141191:CAS:528:DC%2BB3cXisVeiur8%3D313090896614089
– reference: ParkSLeeEJRimCHSeongJPlasma cell-free DNA as a predictive marker after radiotherapy for hepatocellular carcinomaYonsei Medical Journal.20185944704791:CAS:528:DC%2BC1cXisVyqurvK297491295949288
– reference: ShaoJWangSWest-SzymanskiDKarpusJShahSGangulySCell-free DNA 5-hydroxymethylcytosine is an emerging marker of acute myeloid leukemiaScientific Reports.2022121124101:CAS:528:DC%2BB38XhvFWnsLbP358590089300744
– reference: PatelABenign vs malignant tumorsJAMA Oncology.202069148832729930
– reference: KhierSLohanLKinetics of circulating cell-free DNA for biomedical applications: Critical appraisal of the literatureFuture Science OA.201844FSO2951:CAS:528:DC%2BC1cXntlegt7w%3D296823275905581
– reference: Ansell SM, editor Non-Hodgkin lymphoma: Diagnosis and treatment. Mayo Clinic Proceedings; 2015: Elsevier.
– reference: MagbanuaMJMSwigartLBWuH-THirstGLYauCWolfDMCirculating tumor DNA in neoadjuvant-treated breast cancer reflects response and survivalAnnals of Oncology.20213222292391:CAS:528:DC%2BB38XhvVKrtbs%3D33232761
– reference: BuedtsLWlodarskaIFinalet-FerreiroJGheysensODehaspeLTousseynTThe landscape of copy number variations in classical Hodgkin lymphoma: A joint KU Leuven and LYSA study on cell-free DNABlood Advances.202157199120021:CAS:528:DC%2BB3MXhs1yrt7vL338439868045498
– reference: ChengJCukKHeilJGolattaMSchottSSohnCCell-free circulating DNA integrity is an independent predictor of impending breast cancer recurrenceOncotarget201783354537289033625589601
– reference: SehnLHGascoyneRDDiffuse large B-cell lymphoma: Optimizing outcome in the context of clinical and biologic heterogeneityBlood2015125122321:CAS:528:DC%2BC2MXmtFKquw%3D%3D25499448
– reference: YanLChenYZhouJZhaoHZhangHWangGDiagnostic value of circulating cell-free DNA levels for hepatocellular carcinomaInternational Journal of Infectious Diseases.20186792971:CAS:528:DC%2BC1cXksFegsQ%3D%3D29229500
– reference: Ye X, Li W, Zhang L, Yu J. Clinical significance of circulating cell-free DNA detection in multiple myeloma: a meta-analysis. Frontiers in Oncology. 2022:520.
– reference: LiBTJankuFJannePAMillsGBMadwaniKAldenRSUltra-deep next generation sequencing (NGS) of plasma cell-free DNA (cfDNA) from patients with advanced lung cancers: results from the Actionable Genome ConsortiumAACR2016764342
– reference: McKayPFieldingPGallop-EvansEHallGWLambertJLeachMGuidelines for the investigation and management of nodular lymphocyte predominant Hodgkin lymphomaBritish Journal of Haematology.20161721324326538004
– reference: KisOKaedbeyRChowSDaneshADowarMLiTCirculating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspiratesNature Communications.2017815086284922265437268
– reference: WuF-TLuLXuWLiJ-YCirculating tumor DNA: Clinical roles in diffuse large B cell lymphomaAnnals of Hematology.201998225526930368587
– reference: DeshpandeSTytarenkoRGWangYBoyleEMAshbyCSchinkeCDMonitoring treatment response and disease progression in myeloma with circulating cell-free DNAEuropean Journal of Haematology.202110622302401:CAS:528:DC%2BB3MXjtV2gtL4%3D33107092
– reference: ChenH-YZhangW-LZhangLYangPLiFYangZ-R5-Hydroxymethylcytosine profiles of cfDNA are highly predictive of R-CHOP treatment response in diffuse large B cell lymphoma patientsClinical Epigenetics.2021131114
– reference: El MessaoudiSRoletFMouliereFThierryARCirculating cell free DNA: Preanalytical considerationsClinica Chimica Acta.2013424222230
– reference: LuoBMaFLiuHHuJRaoLLiuCCell-free DNA methylation markers for differential diagnosis of hepatocellular carcinomaBMC Medicine.202220112
– reference: BarataAWoodWAChoiSWJimHSUnmet needs for psychosocial care in hematologic malignancies and hematopoietic cell transplantCurrent Hematologic Malignancy Reports.201611428028727113094
– reference: MoreauPSan MiguelJSonneveldPMateosM-VZamagniEAvet-LoiseauHMultiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology.201728Suppl_4iv52iv611:STN:280:DC%2BC1crit1amuw%3D%3D28453614
– reference: ManierSParkJCapellettiMBustorosMFreemanSHaGWhole-exome sequencing of cell-free DNA and circulating tumor cells in multiple myelomaNature Communications.20189116911:STN:280:DC%2BC1MjnsFGhsw%3D%3D297039825923255
– reference: KohlerCRadpourRBarekatiZAsadollahiRBitzerJWightELevels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumorsMolecular Cancer.200981105199226042780981
– reference: LiSWangXLiYLaiHLiuYJinLNon-invasive analysis of tumor mutation profiles and druggable mutations by sequencing of cell free DNA of Chinese metastatic breast cancer patientsThoracic Cancer.20191048078141:CAS:528:DC%2BC1MXntFGqsrc%3D307934916449225
– reference: ZhangYXuYZhongWZhaoJChenMZhangLTotal DNA input is a crucial determinant of the sensitivity of plasma cell-free DNA EGFR mutation detection using droplet digital PCROncotarget2017845861587328052016
– reference: OhC-MWonY-JJungK-WKongH-JChoHLeeJ-KCancer statistics in Korea: Incidence, mortality, survival, and prevalence in 2013Cancer Research and Treatment2016482436269873954843732
– reference: WaldschmidtJMYeeAJVijaykumarTPintoRAFredeJAnandPCell-free DNA for the detection of emerging treatment failure in relapsed/refractory multiple myelomaLeukemia2022364107810871:CAS:528:DC%2BB38XptlartLY%3D350276568983453
– reference: BennDKVigPSEstimation of x-ray radiation related cancers in US dental offices: Is it worth the risk?Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology.2021132559760833741287
– reference: SkinniderBFMakTWThe role of cytokines in classical Hodgkin lymphomaBlood20029912428342971:CAS:528:DC%2BD38XksFGlu74%3D12036854
– reference: BoardREWardleyAMDixonJMArmstrongACHowellSRenshawLDetection of PIK3CA mutations in circulating free DNA in patients with breast cancerBreast Cancer Research and Treatment.201012024614671:CAS:528:DC%2BC3cXjtlahurg%3D20107891
– reference: LeighlNBPageRDRaymondVMDanielDBDiversSGReckampKLClinical utility of comprehensive cell-free DNA analysis to identify genomic biomarkers in patients with newly diagnosed metastatic non-small cell lung cancerClinical Cancer Research.2019251546911:CAS:528:DC%2BB3cXhs1Chsb3I30988079
– reference: LissaDRoblesAIComprehensive genomic analysis of circulating tumor DNA for patients with advanced non-small cell lung cancerAnn Transl Med.201975801:CAS:528:DC%2BB3cXhsVequ7g%3D310199306462649
– reference: TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA: A Cancer Journal For Clinicians.20156528710825651787
– reference: HeitzerEHaqueISRobertsCESpeicherMRCurrent and future perspectives of liquid biopsies in genomics-driven oncologyNature Reviews Genetics.201920271881:CAS:528:DC%2BC1cXitFersbrF30410101
– reference: Fernández-MirandaIPedrosaLLlanosMFrancoFFGómezSMartín-AcostaPMonitoring of circulating tumor DNA predicts response to treatment and early progression in follicular lymphoma: Results of a prospective pilot studyClinical Cancer Research.20232920936269794
– reference: BessiLViaillyP-JBohersERuminyPMaingonnatCBertrandPSomatic mutations of cell-free circulating DNA detected by targeted next-generation sequencing and digital droplet PCR in classical Hodgkin lymphomaLeukemia & Lymphoma.20196024985021:CAS:528:DC%2BC1cXhsVOlt7zM
– reference: YangRPapariniAMonisPRyanUComparison of next-generation droplet digital PCR (ddPCR) with quantitative PCR (qPCR) for enumeration of Cryptosporidium oocysts in faecal samplesInternational Journal for Parasitology.20144414110511131:CAS:528:DC%2BC2cXhs1SqtbnL25229177
– reference: KumarRKatarePBLentzSRModiAJSharathkumarAADayalSThrombotic potential during pediatric acute lymphoblastic leukemia induction: Role of cell-free DNAResearch and Practice in Thrombosis and Haemostasis.2021551:CAS:528:DC%2BB38XhtlKjsLg%3D343373078312738
– reference: E F, T K, G T. Serum Expression of seven MicroRNAs in chronic lymphocytic leukemia patients. J Blood Med. 2020;11(1):97–102.
– reference: DawsonS-JTsuiDWMurtazaMBiggsHRuedaOMChinS-FAnalysis of circulating tumor DNA to monitor metastatic breast cancerNew England Journal of Medicine.201336813119912091:CAS:528:DC%2BC3sXlt1SqsrY%3D23484797
– reference: BunzFPrinciples of cancer genetics2008BerlinSpringer
– reference: StewartCMTsuiDWCirculating cell-free DNA for non-invasive cancer managementCancer Genetics.201822816917929625863
– reference: PhallenJLealAWoodwardBDFordePMNaidooJMarroneKAEarly noninvasive detection of response to targeted therapy in non-small cell lung cancerCancer Research.2019796120412131:CAS:528:DC%2BC1MXhtFGhurfE30573519
– reference: UehiroNSatoFPuFTanakaSKawashimaMKawaguchiKCirculating cell-free DNA-based epigenetic assay can detect early breast cancerBreast Cancer Research.2016181129279931615168705
– reference: Dowler NygaardASpindlerK-LGPallisgaardNAndersenRFJakobsenALevels of cell-free DNA and plasma KRAS during treatment of advanced NSCLCOncology Reports.201431296997424316734
– reference: SuY-HKimAKJainSLiquid biopsies for hepatocellular carcinomaTranslational Research.201820184300560686483086
– reference: AttaliDBidshahriRHaynesCBryanJddpcr: an R package and web application for analysis of droplet digital PCR dataF1000Research.201651411277036665031129
– reference: Esposito AbateRPasqualeRFeniziaFRachiglioAMRomaCBergantinoFThe role of circulating free DNA in the management of NSCLCExpert Review of Anticancer Therapy.201919119281:CAS:528:DC%2BC1cXisVGnurvK30462523
– reference: RossiDDiopFSpaccarotellaEMontiSZanniMRasiSDiffuse large B-cell lymphoma genotyping on the liquid biopsyBlood, The Journal of the American Society of Hematology.201712914194719571:CAS:528:DC%2BC2sXhtV2jur%2FK
– reference: CristianoSLealAPhallenJFikselJAdleffVBruhmDCGenome-wide cell-free DNA fragmentation in patients with cancerNature20195701
– reference: RauschCRothenberg-ThurleyMBuergerSATschuriSDufourANeusserMDouble drop-off droplet digital pcr: A novel, versatile tool for mutation screening and residual disease monitoring in acute myeloid leukemia using cellular or cell-free DNAThe Journal of Molecular Diagnostics.20212389759851:CAS:528:DC%2BB3MXhvFGjsbbO34020042
– reference: BeaverJAJelovacDBalukrishnaSCochranRLCroessmannSZabranskyDJDetection of cancer DNA in plasma of patients with early-stage breast cancerClinical Cancer Research.20142010264326501:CAS:528:DC%2BC2cXnvF2gtb0%3D245041254024333
– reference: LiCHeQLiangHHeJLiangW41P Diagnostic accuracy of droplet digital PCR (ddPCR) and amplification refractory mutation system PCR (ARMS-PCR) for detecting EGFR mutation in cell-free DNA of advanced lung cancer: A meta-analysisAnnals of Oncology.201930Supplement 2mdz073.20
– reference: KooleSNVessiesDCSchuurbiersMMKramerASchoutenRDDegelingKCell-free DNA at diagnosis for stage IV non-small cell lung cancer: Costs, time to diagnosis and clinical relevanceCancers202214717831:CAS:528:DC%2BB38XhtFWqsLvJ354065558997553
– reference: ElazezyMJoosseSATechniques of using circulating tumor DNA as a liquid biopsy component in cancer managementComputational and Structural Biotechnology Journal.2018163703781:CAS:528:DC%2BC1cXhvFWhsr%2FI303646566197739
– reference: KustanovichASchwartzRPeretzTGrinshpunALife and death of circulating cell-free DNACancer Biology and Therapy2019208105710671:CAS:528:DC%2BC1MXns1Gis78%3D309901326606043
– reference: MattiuzziCLippiGCurrent cancer epidemiologyJournal of Epidemiology and Global Health.201994217318541627310786
– reference: IlhanBGuneriPWilder-SmithPThe contribution of artificial intelligence to reducing the diagnostic delay in oral cancerOral Oncology.2021116337115828144066
– reference: MiaoYFanYZhangLMaTLiRClinical value of plasma cfDNA concentration and integrity in breast cancer patientsCellular and Molecular Biology.2019656647231472049
– reference: ZhangYLiMGaoXChenYLiuTNanotechnology in cancer diagnosis: Progress, challenges and opportunitiesJournal of Hematology and Oncology.2019121113
– reference: PezzutoFBuonaguroLBuonaguroFTorneselloMThe role of circulating free DNA and microRNA in non-invasive diagnosis of HBV-and HCV-related hepatocellular carcinomaInternational Journal of Molecular Sciences.20181941007295972595979406
– reference: HeGChenYZhuCZhouJXieXFeiRApplication of plasma circulating cell-free DNA detection to the molecular diagnosis of hepatocellular carcinomaAmerican Journal of Translational Research.201911314281:CAS:528:DC%2BC1MXisVSit7nI309721726456549
– reference: HuangAZhangXZhouS-LCaoYHuangX-WFanJPlasma circulating cell-free DNA integrity as a promising biomarker for diagnosis and surveillance in patients with hepatocellular carcinomaJournal of Cancer.201671317981:CAS:528:DC%2BC1cXpt1Oqs78%3D276989185039362
– reference: MandelPLes acides nucleiques du plasma sanguin chez 1 hommeCR Seances Soc Biol Fil.19481422412431:CAS:528:DyaH1cXjvFSrsg%3D%3D
– reference: RoschewskiMStaudtLMWilsonWHDynamic monitoring of circulating tumor DNA in non-Hodgkin lymphomaBlood201612725312731321:CAS:528:DC%2BC28Xhs1entL%2FP270810974920019
– reference: ArmitageJOGascoyneRDLunningMACavalliFNon-hodgkin lymphomaThe Lancet.201739010091298310
– reference: FutrealPACoinLMarshallMDownTHubbardTWoosterRA census of human cancer genesNature Reviews Cancer2004431771831:CAS:528:DC%2BD2cXhs1Ggsrg%3D149938992665285
– reference: CaersJGarderetLKortümKMO’DwyerMEVandeDonkNWBinderMEuropean Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and whenHaematologica201810311177217841:CAS:528:DC%2BC1MXhtFyrt7nN301710316278986
– reference: TodenhöferTStrussWJSeilerRWyattAWBlackPCLiquid biopsy-analysis of circulating tumor DNA (ctDNA) in bladder cancerBladder Cancer.201841192929430504
– reference: HatipoğluTEsmeray SönmezEHuXYuanHErşenDanyeliAŞeyhanlıAPlasma concentrations and cancer-associated mutations in cell-free circulating DNA of treatment-naive follicular lymphoma for improved non-invasive diagnosis and prognosisFrontiers in Oncology.2022122395
– reference: Guerriero P, Moshiri F, Lupini L, Sabbioni S, Negrini M, Callegari E. Circulating tumor DNAs and non-coding RNAs as potential biomarkers for hepatocellular carcinoma diagnosis, prognosis and response to therapy. Hepatoma Research. 2019.
– reference: RenSRenXGuoHLiangLWeiKGuoLConcentration and integrity indexes of urine cell-free DNA as promising biomarkers for early lung cancer diagnosisPersonalized Medicine.202118212913933565322
– reference: WuXLiJGassaABuchnerDAlakusHDongQCirculating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinomaInternational Journal of Biological Sciences.202016915511:CAS:528:DC%2BB3cXhvVSjsL7J322263017097921
– reference: PhallenJSausenMAdleffVLealAHrubanCWhiteJDirect detection of early-stage cancers using circulating tumor DNAScience Translational Medicine201792415
– reference: EtzioniRUrbanNRamseySMcIntoshMSchwartzSReidBThe case for early detectionNature Reviews Cancer.2003342432521:CAS:528:DC%2BD3sXisFajt7w%3D12671663
– reference: CervenaKVodickaPVymetalkovaVDiagnostic and prognostic impact of cell-free DNA in human cancers: Systematic reviewMutation Research/Reviews in Mutation Research.20197811001:CAS:528:DC%2BC1MXhtVSntbjL31416571
– reference: ShiLZhaoXYanXLiuYLiuYCaoHAggressive disseminated Rhizomucor pusillus infection in a Ph-like acute lymphoblastic leukemia patient: Early detection by cell-free DNA next-generation sequencingJournal of Infection and Chemotherapy.20222834594641:CAS:528:DC%2BB38XhtVamsrjI34955408
– reference: ShanklandKRArmitageJOHancockBWNon-hodgkin lymphomaThe Lancet.20123809844848857
– reference: SobeskySMammadovaLCirilloMDreesEEMattlenerJDörrHIn-depth cell-free DNA sequencing reveals genomic landscape of Hodgkin’s lymphoma and facilitates ultrasensitive residual disease detectionMedicine2021210117193.e111:CAS:528:DC%2BB38XhvVGks7rJ
– reference: SunRMedeirosLJYoungKHDiagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicineModern Pathology.2016291011181:CAS:528:DC%2BC28XhtFansbjN27363492
– reference: YanY-YGuoQ-RWangF-HAdhikariRZhuZ-YZhangH-YCell-free DNA: Hope and potential application in cancerFrontiers in Cell and Developmental Biology.20219639233336930047938321
– reference: GaoQZengQWangZLiCXuYCuiPCirculating cell-free DNA for cancer early detectionThe Innovation.2022341002591:CAS:528:DC%2BB38XitVemtL3I356475729133648
– reference: EichenauerDAlemanBAndréMFedericoMHutchingsMIllidgeTHodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology.201829iv191:STN:280:DC%2BC1MfmslKisA%3D%3D29796651
– reference: LittleSAmplification-refractory mutation system (ARMS) analysis of point mutationsCurrent Protocols in Human Genetics.1995719.8.19.8.12
– reference: de la Cruz-MerinoLLejeuneMNogales FernándezEHenao CarrascoFGrueso LópezAIllescasVacasARole of immune escape mechanisms in Hodgkin's lymphoma development and progression: A whole new world with therapeutic implicationsClinical and Developmental Immunology.20122012124
– reference: WangYSpringerSZhangMMcMahonKWKindeIDobbynLDetection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cordProceedings of the National academy of Sciences of the United States of America201511231970497091:CAS:528:DC%2BC2MXhtF2hsrbM261957504534284
– reference: TeoYVCapriMMorsianiCPizzaGFariaAMCFranceschiCCell-free DNA as a biomarker of agingAging Cell201918130575273
– reference: HohausSGiacheliaMMassiniGMansuetoGVannataBBozzoliVCell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomasAnnals of Oncology.2009208140814131:STN:280:DC%2BD1MrjtlKksQ%3D%3D19465421
– reference: LeonSShapiroBSklaroffDYarosMFree DNA in the serum of cancer patients and the effect of therapyCancer Research.19773736466501:CAS:528:DyaE2sXhtFyqsLc%3D837366
– reference: SpinaVBruscagginACuccaroAMartiniMDi TraniMForestieriGCirculating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphomaBlood201813122241324251:CAS:528:DC%2BC1cXhvFaqsb7N29449275
– reference: DreylingMGhielminiMRuleSSallesGVitoloULadettoMNewly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology.201627Suppl_5v83v901:STN:280:DC%2BC2srgs1Ojtw%3D%3D27664263
– reference: YangZQiWSunLZhouHZhouBHuYDNA methylation analysis of selected genes for the detection of early-stage lung cancer using circulating cell-free DNAAdvances in Clinical and Experimental Medicine201928335536030516882
– reference: YuHLiuMQiuHYangKUrinary and plasma cell-free DNA comparison for lung cancer patients treated with epidermal growth factor receptor—thyroxine kinase inhibitorsThe American Journal of the Medical Sciences.20193571293630611317
– reference: ChinenABGuanCMFerrerJRBarnabySNMerkelTJMirkinCANanoparticle probes for the detection of cancer biomarkers, cells, and tissues by fluorescenceChemical Reviews.20151151910530105741:CAS:528:DC%2BC2MXhsVahs7rN263131385457709
– reference: JordanCTCancer stem cell biology: From leukemia to solid tumorsCurrent Opinion in Cell Biology.20041667087121:CAS:528:DC%2BD2cXpsVOruro%3D15530785
– reference: CabelLProudhonCBuecherBPiergaJ-YBidardF-CCirculating tumor DNA detection in hepatocellular carcinoma2018OxfordOxford University Press
– reference: TanLGKhooMLAccuracy of fine needle aspiration cytology and frozen section histopathology for lesions of the major salivary glandsAnnals Academy of Medicine Singapore.2006354242
– reference: FettkeHKwanEMAzadAACell-free DNA in cancer: Current insightsCellular Oncology (Dordrecht)201942113281:CAS:528:DC%2BC1cXitVChsrbJ
– reference: PantelKAlix-PanabièresCLiquid biopsy and minimal residual disease—Latest advances and implications for cureNature Reviews Clinical Oncology.20191674094241:CAS:528:DC%2BC1MXhtVyjtrnI30796368
– volume: 112
  start-page: 9704
  issue: 31
  year: 2015
  ident: 976_CR29
  publication-title: Proceedings of the National academy of Sciences of the United States of America
  doi: 10.1073/pnas.1511694112
– volume: 16
  start-page: 407
  issue: 4
  year: 2002
  ident: 976_CR10
  publication-title: Journal of Magnetic Resonance Imaging.
  doi: 10.1002/jmri.10176
– volume: 29
  start-page: iv19
  year: 2018
  ident: 976_CR88
  publication-title: Annals of Oncology.
  doi: 10.1093/annonc/mdy080
– volume: 23
  start-page: 975
  issue: 8
  year: 2021
  ident: 976_CR71
  publication-title: The Journal of Molecular Diagnostics.
  doi: 10.1016/j.jmoldx.2021.05.001
– volume: 172
  start-page: 32
  issue: 1
  year: 2016
  ident: 976_CR92
  publication-title: British Journal of Haematology.
  doi: 10.1111/bjh.13842
– volume: 12
  start-page: 1
  issue: 1
  year: 2019
  ident: 976_CR9
  publication-title: Journal of Hematology and Oncology.
  doi: 10.1186/s13045-016-0379-6
– volume: 12
  start-page: 12410
  issue: 1
  year: 2022
  ident: 976_CR72
  publication-title: Scientific Reports.
  doi: 10.1038/s41598-022-16685-3
– ident: 976_CR124
  doi: 10.2147/JBM.S230842
– volume: 88
  start-page: 1
  year: 2018
  ident: 976_CR31
  publication-title: European Journal of Cancer.
  doi: 10.1016/j.ejca.2017.10.029
– volume: 54
  start-page: 114
  issue: 2
  year: 2019
  ident: 976_CR103
  publication-title: Blood Research.
  doi: 10.5045/br.2019.54.2.114
– volume: 65
  start-page: 64
  issue: 6
  year: 2019
  ident: 976_CR122
  publication-title: Cellular and Molecular Biology.
  doi: 10.14715/cmb/2019.65.6.11
– volume: 99
  start-page: 4283
  issue: 12
  year: 2002
  ident: 976_CR87
  publication-title: Blood
  doi: 10.1182/blood-2002-01-0099
– volume: 424
  start-page: 222
  year: 2013
  ident: 976_CR68
  publication-title: Clinica Chimica Acta.
  doi: 10.1016/j.cca.2013.05.022
– volume: 781
  start-page: 100
  year: 2019
  ident: 976_CR43
  publication-title: Mutation Research/Reviews in Mutation Research.
  doi: 10.1016/j.mrrev.2019.05.002
– volume: 16
  start-page: 1551
  issue: 9
  year: 2020
  ident: 976_CR17
  publication-title: International Journal of Biological Sciences.
  doi: 10.7150/ijbs.44024
– volume: 44
  start-page: 1105
  issue: 14
  year: 2014
  ident: 976_CR38
  publication-title: International Journal for Parasitology.
  doi: 10.1016/j.ijpara.2014.08.004
– volume: 5
  start-page: 1411
  year: 2016
  ident: 976_CR37
  publication-title: F1000Research.
  doi: 10.12688/f1000research.9022.1
– volume: 65
  start-page: 559
  issue: 4
  year: 2019
  ident: 976_CR22
  publication-title: Clinical Chemistry
  doi: 10.1373/clinchem.2018.297549
– volume: 67
  start-page: 92
  year: 2018
  ident: 976_CR41
  publication-title: International Journal of Infectious Diseases.
  doi: 10.1016/j.ijid.2017.12.002
– volume: 60
  start-page: 498
  issue: 2
  year: 2019
  ident: 976_CR90
  publication-title: Leukemia & Lymphoma.
  doi: 10.1080/10428194.2018.1492123
– volume: 127
  start-page: 2055
  issue: 17
  year: 2016
  ident: 976_CR106
  publication-title: Blood
  doi: 10.1182/blood-2015-11-624288
– volume: 12
  start-page: dmm036863
  issue: 2
  year: 2019
  ident: 976_CR52
  publication-title: Disease Models and Mechanisms.
  doi: 10.1242/dmm.036863
– volume: 380
  start-page: 848
  issue: 9844
  year: 2012
  ident: 976_CR91
  publication-title: The Lancet.
  doi: 10.1016/S0140-6736(12)60605-9
– volume: 29
  start-page: 209
  year: 2023
  ident: 976_CR109
  publication-title: Clinical Cancer Research.
  doi: 10.1158/1078-0432.CCR-22-1654
– volume: 103
  start-page: 1772
  issue: 11
  year: 2018
  ident: 976_CR75
  publication-title: Haematologica
  doi: 10.3324/haematol.2018.189159
– volume: 20
  start-page: 1057
  issue: 8
  year: 2019
  ident: 976_CR26
  publication-title: Cancer Biology and Therapy
  doi: 10.1080/15384047.2019.1598759
– volume: 7
  start-page: 80
  issue: 5
  year: 2019
  ident: 976_CR54
  publication-title: Annals of Translational Medicine.
  doi: 10.21037/atm.2018.12.57
– volume: 6
  start-page: 1488
  issue: 9
  year: 2020
  ident: 976_CR6
  publication-title: JAMA Oncology.
  doi: 10.1001/jamaoncol.2020.2592
– volume: 116
  year: 2021
  ident: 976_CR8
  publication-title: Oral Oncology.
  doi: 10.1016/j.oraloncology.2021.105254
– volume: 12
  start-page: 2395
  year: 2022
  ident: 976_CR110
  publication-title: Frontiers in Oncology.
  doi: 10.3389/fonc.2022.870487
– volume: 65
  start-page: 87
  issue: 2
  year: 2015
  ident: 976_CR2
  publication-title: CA: A Cancer Journal For Clinicians.
– volume: 18
  issue: 1
  year: 2019
  ident: 976_CR23
  publication-title: Aging Cell
– volume: 16
  start-page: 370
  year: 2018
  ident: 976_CR35
  publication-title: Computational and Structural Biotechnology Journal.
  doi: 10.1016/j.csbj.2018.10.002
– volume: 28
  start-page: 355
  issue: 3
  year: 2019
  ident: 976_CR65
  publication-title: Advances in Clinical and Experimental Medicine
  doi: 10.17219/acem/84935
– volume: 8
  start-page: 54537
  issue: 33
  year: 2017
  ident: 976_CR111
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.17384
– volume: 16
  start-page: 409
  issue: 7
  year: 2019
  ident: 976_CR15
  publication-title: Nature Reviews Clinical Oncology.
  doi: 10.1038/s41571-019-0187-3
– volume: 5
  start-page: 1991
  issue: 7
  year: 2021
  ident: 976_CR98
  publication-title: Blood Advances.
  doi: 10.1182/bloodadvances.2020003039
– volume: 2019
  start-page: 1
  year: 2019
  ident: 976_CR56
  publication-title: Disease Markers.
  doi: 10.1155/2019/7954921
– ident: 976_CR47
  doi: 10.20517/2394-5079.2018.108
– volume: 2
  start-page: 1171
  issue: 10
  year: 2021
  ident: 976_CR97
  publication-title: Medicine
  doi: 10.1016/j.medj.2021.09.002
– volume: 4
  start-page: FSO295
  issue: 4
  year: 2018
  ident: 976_CR30
  publication-title: Future Science OA.
  doi: 10.4155/fsoa-2017-0140
– volume: 12
  start-page: 5060
  issue: 1
  year: 2021
  ident: 976_CR64
  publication-title: Nature Communications.
  doi: 10.1038/s41467-021-24994-w
– volume: 50
  start-page: 1007
  issue: 10
  year: 2018
  ident: 976_CR33
  publication-title: Acta Biochimica et Biophysica Sinica.
  doi: 10.1093/abbs/gmy104
– volume: 131
  start-page: 2413
  issue: 22
  year: 2018
  ident: 976_CR89
  publication-title: Blood
  doi: 10.1182/blood-2017-11-812073
– volume: 18
  start-page: 129
  issue: 1
  year: 2016
  ident: 976_CR113
  publication-title: Breast Cancer Research.
  doi: 10.1186/s13058-016-0788-z
– volume: 20
  start-page: 1
  year: 2021
  ident: 976_CR120
  publication-title: Molecular Cancer.
– volume: 120
  start-page: 461
  issue: 2
  year: 2010
  ident: 976_CR115
  publication-title: Breast Cancer Research and Treatment.
  doi: 10.1007/s10549-010-0747-9
– volume: 36
  start-page: 1078
  issue: 4
  year: 2022
  ident: 976_CR80
  publication-title: Leukemia
  doi: 10.1038/s41375-021-01492-y
– volume: 98
  start-page: 255
  issue: 2
  year: 2019
  ident: 976_CR102
  publication-title: Annals of Hematology.
  doi: 10.1007/s00277-018-3529-9
– volume: 8
  start-page: 15086
  year: 2017
  ident: 976_CR78
  publication-title: Nature Communications.
  doi: 10.1038/ncomms15086
– volume: 17
  start-page: 1
  issue: 1
  year: 2019
  ident: 976_CR51
  publication-title: Journal of Translational Medicine.
  doi: 10.1186/s12967-019-2079-9
– volume: 14
  start-page: 1783
  issue: 7
  year: 2022
  ident: 976_CR63
  publication-title: Cancers
  doi: 10.3390/cancers14071783
– volume: 570
  start-page: 1
  year: 2019
  ident: 976_CR53
  publication-title: Nature
  doi: 10.1038/s41586-019-1272-6
– volume: 142
  start-page: 241
  year: 1948
  ident: 976_CR25
  publication-title: CR Seances Soc Biol Fil.
– volume: 125
  start-page: 22
  issue: 1
  year: 2015
  ident: 976_CR100
  publication-title: Blood
  doi: 10.1182/blood-2014-05-577189
– volume: 20
  start-page: 71
  issue: 2
  year: 2019
  ident: 976_CR16
  publication-title: Nature Reviews Genetics.
  doi: 10.1038/s41576-018-0071-5
– volume-title: Principles of cancer genetics
  year: 2008
  ident: 976_CR1
  doi: 10.1007/978-1-4020-6784-6
– volume: 55
  start-page: 136
  year: 2018
  ident: 976_CR74
  publication-title: Cancer Epidemiology.
  doi: 10.1016/j.canep.2018.06.003
– volume: 35
  start-page: 242
  issue: 4
  year: 2006
  ident: 976_CR12
  publication-title: Annals Academy of Medicine Singapore.
  doi: 10.47102/annals-acadmedsg.V35N4p242
– volume: 5
  start-page: 39
  issue: 1
  year: 2020
  ident: 976_CR13
  publication-title: Signal Transduction and Targeted Therapy.
  doi: 10.1038/s41392-020-0133-y
– volume: 6
  start-page: 247
  issue: 3
  year: 2015
  ident: 976_CR46
  publication-title: Journal of Cancer.
  doi: 10.7150/jca.10747
– volume: 11
  start-page: 1428
  issue: 3
  year: 2019
  ident: 976_CR49
  publication-title: American Journal of Translational Research.
– volume: 59
  start-page: 470
  issue: 4
  year: 2018
  ident: 976_CR21
  publication-title: Yonsei Medical Journal.
  doi: 10.3349/ymj.2018.59.4.470
– volume: 4
  start-page: 19
  issue: 1
  year: 2018
  ident: 976_CR36
  publication-title: Bladder Cancer.
  doi: 10.3233/BLC-170140
– volume: 10
  start-page: 323
  issue: 2
  year: 2019
  ident: 976_CR96
  publication-title: Journal of Cancer.
  doi: 10.7150/jca.27615
– volume: 129
  start-page: 1947
  issue: 14
  year: 2017
  ident: 976_CR105
  publication-title: Blood, The Journal of the American Society of Hematology.
– volume: 62
  start-page: 541
  issue: 4
  year: 2020
  ident: 976_CR99
  publication-title: Turkish Journal of Pediatrics.
  doi: 10.24953/turkjped.2020.04.003
– volume: 12
  issue: 7
  year: 2016
  ident: 976_CR27
  publication-title: PLoS Genetics.
  doi: 10.1371/journal.pgen.1006162
– volume: 13
  start-page: 1
  issue: 1
  year: 2021
  ident: 976_CR104
  publication-title: Clinical Epigenetics.
  doi: 10.1186/s13148-020-00979-2
– volume: 37
  start-page: 646
  issue: 3
  year: 1977
  ident: 976_CR18
  publication-title: Cancer Research.
– volume: 9
  start-page: 639233
  year: 2021
  ident: 976_CR14
  publication-title: Frontiers in Cell and Developmental Biology.
  doi: 10.3389/fcell.2021.639233
– volume: 134
  year: 2018
  ident: 976_CR39
  publication-title: JoVE (Journal of Visualized Experiments).
– volume: 31
  start-page: 969
  issue: 2
  year: 2014
  ident: 976_CR123
  publication-title: Oncology Reports.
  doi: 10.3892/or.2013.2906
– volume: 2
  start-page: 807
  issue: 7
  year: 2018
  ident: 976_CR108
  publication-title: Blood Advances.
  doi: 10.1182/bloodadvances.2017015164
– volume: 27
  start-page: v83
  issue: Suppl_5
  year: 2016
  ident: 976_CR107
  publication-title: Annals of Oncology.
  doi: 10.1093/annonc/mdw400
– volume: 10
  start-page: 807
  issue: 4
  year: 2019
  ident: 976_CR117
  publication-title: Thoracic Cancer.
  doi: 10.1111/1759-7714.13002
– volume: 8
  start-page: 5861
  issue: 4
  year: 2017
  ident: 976_CR125
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.14390
– volume: 4
  start-page: 177
  issue: 3
  year: 2004
  ident: 976_CR24
  publication-title: Nature Reviews Cancer
  doi: 10.1038/nrc1299
– volume: 201
  start-page: 84
  year: 2018
  ident: 976_CR45
  publication-title: Translational Research.
  doi: 10.1016/j.trsl.2018.07.001
– volume: 357
  start-page: 29
  issue: 1
  year: 2019
  ident: 976_CR60
  publication-title: The American Journal of the Medical Sciences.
  doi: 10.1016/j.amjms.2018.10.006
– volume: 11
  start-page: 280
  issue: 4
  year: 2016
  ident: 976_CR67
  publication-title: Current Hematologic Malignancy Reports.
  doi: 10.1007/s11899-016-0328-z
– volume: 7
  start-page: 9.8.1
  issue: 1
  year: 1995
  ident: 976_CR40
  publication-title: Current Protocols in Human Genetics.
  doi: 10.1002/0471142905.hg0908s07
– volume: 20
  start-page: 2643
  issue: 10
  year: 2014
  ident: 976_CR116
  publication-title: Clinical Cancer Research.
  doi: 10.1158/1078-0432.CCR-13-2933
– volume: 9
  start-page: 217
  issue: 4
  year: 2019
  ident: 976_CR3
  publication-title: Journal of Epidemiology and Global Health.
  doi: 10.2991/jegh.k.191008.001
– volume: 29
  start-page: 1118
  issue: 10
  year: 2016
  ident: 976_CR85
  publication-title: Modern Pathology.
  doi: 10.1038/modpathol.2016.92
– volume: 7
  start-page: 1798
  issue: 13
  year: 2016
  ident: 976_CR50
  publication-title: Journal of Cancer.
  doi: 10.7150/jca.15618
– volume-title: Circulating tumor DNA detection in hepatocellular carcinoma
  year: 2018
  ident: 976_CR42
– volume: 42
  start-page: 13
  issue: 1
  year: 2019
  ident: 976_CR28
  publication-title: Cellular Oncology (Dordrecht)
  doi: 10.1007/s13402-018-0413-5
– volume: 368
  start-page: 1199
  issue: 13
  year: 2013
  ident: 976_CR114
  publication-title: New England Journal of Medicine.
  doi: 10.1056/NEJMoa1213261
– volume: 3
  start-page: 243
  issue: 4
  year: 2003
  ident: 976_CR7
  publication-title: Nature Reviews Cancer.
  doi: 10.1038/nrc1041
– volume: 19
  start-page: 1007
  issue: 4
  year: 2018
  ident: 976_CR44
  publication-title: International Journal of Molecular Sciences.
  doi: 10.3390/ijms19041007
– volume: 3
  start-page: 100259
  issue: 4
  year: 2022
  ident: 976_CR20
  publication-title: The Innovation.
  doi: 10.1016/j.xinn.2022.100259
– volume: 2012
  start-page: 1
  year: 2012
  ident: 976_CR86
  publication-title: Clinical and Developmental Immunology.
  doi: 10.1155/2012/756353
– volume: 25
  start-page: 4691
  issue: 15
  year: 2019
  ident: 976_CR58
  publication-title: Clinical Cancer Research.
  doi: 10.1158/1078-0432.CCR-19-0624
– volume: 9
  start-page: 1691
  issue: 1
  year: 2018
  ident: 976_CR79
  publication-title: Nature Communications.
  doi: 10.1038/s41467-018-04001-5
– volume: 9
  start-page: 2415
  year: 2017
  ident: 976_CR19
  publication-title: Science Translational Medicine
  doi: 10.1126/scitranslmed.aan2415
– volume: 91
  start-page: 719
  issue: 7
  year: 2016
  ident: 976_CR76
  publication-title: American Journal of Hematology.
  doi: 10.1002/ajh.24402
– volume: 27
  start-page: 154
  issue: 1
  year: 2016
  ident: 976_CR126
  publication-title: Annals of Oncology
  doi: 10.1093/annonc/mdv498
– volume: 7
  start-page: 80
  issue: 5
  year: 2019
  ident: 976_CR34
  publication-title: Ann Transl Med.
  doi: 10.21037/atm.2018.12.57
– volume: 79
  start-page: 1204
  issue: 6
  year: 2019
  ident: 976_CR57
  publication-title: Cancer Research.
  doi: 10.1158/0008-5472.CAN-18-1082
– ident: 976_CR81
  doi: 10.3389/fonc.2022.852573
– volume: 32
  start-page: 229
  issue: 2
  year: 2021
  ident: 976_CR118
  publication-title: Annals of Oncology.
  doi: 10.1016/j.annonc.2020.11.007
– volume: 20
  start-page: 1408
  issue: 8
  year: 2009
  ident: 976_CR94
  publication-title: Annals of Oncology.
  doi: 10.1093/annonc/mdp006
– volume: 48
  start-page: 436
  issue: 2
  year: 2016
  ident: 976_CR66
  publication-title: Cancer Research and Treatment
  doi: 10.4143/crt.2016.089
– volume: 16
  start-page: 2279
  issue: 2
  year: 2018
  ident: 976_CR70
  publication-title: Oncology Letters.
– volume: 20
  start-page: 1
  year: 2022
  ident: 976_CR48
  publication-title: BMC Medicine.
  doi: 10.1186/s12916-021-02182-3
– volume: 16
  start-page: 708
  issue: 6
  year: 2004
  ident: 976_CR5
  publication-title: Current Opinion in Cell Biology.
  doi: 10.1016/j.ceb.2004.09.002
– volume: 18
  start-page: 129
  issue: 2
  year: 2021
  ident: 976_CR62
  publication-title: Personalized Medicine.
  doi: 10.2217/pme-2020-0019
– ident: 976_CR93
  doi: 10.1016/j.mayocp.2015.04.025
– volume: 127
  start-page: 3127
  issue: 25
  year: 2016
  ident: 976_CR95
  publication-title: Blood
  doi: 10.1182/blood-2016-03-635219
– volume: 390
  start-page: 298
  issue: 10091
  year: 2017
  ident: 976_CR84
  publication-title: The Lancet.
  doi: 10.1016/S0140-6736(16)32407-2
– volume: 132
  start-page: 597
  issue: 5
  year: 2021
  ident: 976_CR4
  publication-title: Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology.
  doi: 10.1016/j.oooo.2021.01.027
– volume: 115
  start-page: 10530
  issue: 19
  year: 2015
  ident: 976_CR11
  publication-title: Chemical Reviews.
  doi: 10.1021/acs.chemrev.5b00321
– volume: 31
  start-page: 395
  issue: 3
  year: 2020
  ident: 976_CR119
  publication-title: Annals of Oncology.
  doi: 10.1016/j.annonc.2019.11.014
– volume: 30
  start-page: mdz073.20
  issue: Supplement 2
  year: 2019
  ident: 976_CR61
  publication-title: Annals of Oncology.
– volume: 187
  start-page: 69
  year: 2021
  ident: 976_CR121
  publication-title: Breast Cancer Research and Treatment.
  doi: 10.1007/s10549-021-06142-6
– volume: 228
  start-page: 169
  year: 2018
  ident: 976_CR32
  publication-title: Cancer Genetics.
  doi: 10.1016/j.cancergen.2018.02.005
– volume: 76
  start-page: 4342
  year: 2016
  ident: 976_CR59
  publication-title: AACR
– volume: 106
  start-page: 230
  issue: 2
  year: 2021
  ident: 976_CR83
  publication-title: European Journal of Haematology.
  doi: 10.1111/ejh.13541
– volume: 101
  start-page: 811
  issue: 4
  year: 2022
  ident: 976_CR82
  publication-title: Annals of Hematology.
  doi: 10.1007/s00277-022-04771-5
– volume: 26
  start-page: v116
  issue: Suppl 5
  year: 2015
  ident: 976_CR101
  publication-title: Annals of Oncology.
  doi: 10.1093/annonc/mdv304
– volume: 19
  start-page: 19
  issue: 1
  year: 2019
  ident: 976_CR55
  publication-title: Expert Review of Anticancer Therapy.
  doi: 10.1080/14737140.2019.1548938
– volume: 28
  start-page: iv52
  issue: Suppl_4
  year: 2017
  ident: 976_CR77
  publication-title: Annals of Oncology.
  doi: 10.1093/annonc/mdx096
– volume: 8
  start-page: 105
  issue: 1
  year: 2009
  ident: 976_CR112
  publication-title: Molecular Cancer.
  doi: 10.1186/1476-4598-8-105
– volume: 5
  issue: 5
  year: 2021
  ident: 976_CR73
  publication-title: Research and Practice in Thrombosis and Haemostasis.
  doi: 10.1002/rth2.12557
– volume: 28
  start-page: 459
  issue: 3
  year: 2022
  ident: 976_CR69
  publication-title: Journal of Infection and Chemotherapy.
  doi: 10.1016/j.jiac.2021.12.007
SSID ssj0021543
Score 2.4181669
SecondaryResourceType review_article
Snippet Diagnosis is the most important step in different diseases, especially in cancers and blood malignancies. There are different methods in order to better...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 3462
SubjectTerms Biochemistry
Biological Techniques
Biomarkers
Biomarkers, Tumor - blood
Biomarkers, Tumor - genetics
Biopsy
Biotechnology
Blood
Blood cancer
blood serum
Breast cancer
Breast carcinoma
breast neoplasms
Cancer
Cell Biology
Chemistry
Chemistry and Materials Science
Circulating Tumor DNA - blood
Circulating Tumor DNA - genetics
Deoxyribonucleic acid
Diagnosis
Disease management
DNA
Hepatocellular carcinoma
hepatoma
Human Genetics
Humans
Invasiveness
Liquid Biopsy - methods
Liver cancer
Lung cancer
Lung carcinoma
lung neoplasms
Malignancy
Morbidity
Neoplasms - blood
Neoplasms - diagnosis
Neoplasms - genetics
Peripheral blood
Protein Science
Review Paper
Solid tumors
Tumor cells
Tumors
SummonAdditionalLinks – databaseName: Biological Science Database
  dbid: M7P
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1JS8QwFH64gh7cl3GjgjcNtumWnIZhdPA0eFDwVrIVhKEdp1Xw3_vSZhYRvXhNU_roe0m-JO99H8AVVYnmiZHE8EiTKFaSSK0MEXEoDfXzEFsasYl0OGQvL_zRHbhVLq1yOic2E7UulT0jvw3tRBqxiPnd8RuxqlH2dtVJaCzDqmVJCJvUvcfZhgvhQZtgn4YkQWzhimba0jlqVcxwxSK2lCEh_PvC9ANt_rgpbRagwfZ_Td-BLQc9vV4bK7uwZIo9WG_FKD_3YHOBmnAfur3CW-DgKAvvtahLr29GIzKYGOPdDXvY5N05gZXas6Um2K1vw2hSHcDz4P6p_0Cc2AJRkc9qwriKpKCMyUBozvM05hLhmUolT7mQzNcsYUJpYaLIhFwKX2Ab7ra0L5SPqOcQVoqyMMfgqVixPI8ZTZssUi2C3JLySMNMjHiAdiCY_ulMOSZyK4gxyuYcytY7GXona7yT8Q5cz94Ztzwcf_Y-m3oic2OyyuZu6MDl7DGOJntFIgpTvlcZ5T7lMYJe_nufEMMqQKCWYp-jNjhmJln6_iCxX7iZRsvcgN_tPfnb3lPYoIil2iyaM1ipJ-_mHNbUR_1aTS6amP8C25oDTw
  priority: 102
  providerName: ProQuest
Title An Investigation into Cell-Free DNA in Different Common Cancers
URI https://link.springer.com/article/10.1007/s12033-023-00976-9
https://www.ncbi.nlm.nih.gov/pubmed/38071680
https://www.proquest.com/docview/3128448480
https://www.proquest.com/docview/2902959239
https://www.proquest.com/docview/3154166379
Volume 66
WOSCitedRecordID wos001118092300001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAVX
  databaseName: SpringerLINK Contemporary 1997-Present
  customDbUrl:
  eissn: 1559-0305
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0021543
  issn: 1073-6085
  databaseCode: RSV
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22
  providerName: Springer Nature
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Li9swEB6apGW3hz7S7W62aXCht1Zgyw9JpyWbB700hKQtuRlJlmEhOCV2Cv33HfmRpKQptBeB5bE9jEeez2jmG4D3VEeJiIwiRgQJCUKtiEq0ITL0laFu6uNM2WyCzWZ8tRLzuigsb7Ldmy3J8kt9KHajtu8Yxhhiiw8iIlrQwXDH7XJcLL_tf7MQFFRp9cwnESKKulTmz_f4PRydYMyT_dEy7Eyf_5_CL-BZDTOdYeUXL-GRybrwpGo8-bMLF6Omz1sXnh5REr6Cu2HmHHFvbDLnISs2zsis12S6NcYZz4Y45YzrxiqFY0tMUGxk3WebX8HX6eTL6BOpmywQHbi8IFzoQEnKufJkIkTKQqEQlmmmBBNScTfhEZc6kSYIjC-UdCXO4V9W4krtItp5De1sk5kbcHSoeZqGnLIyezSRXmrJeJThJkQcQHvgNbaOdc1AbhthrOMDd7I1WYwmi0uTxaIHH_bXfK_4N_4q3W9eYVyvxTz2bQgOeMDdHrzbn0Yj260RmZnNLo-pcKkIEeyK8zI-OpaHAI2hzHXlHnuVLG2_F9knfGx84aDAeX1v_038DVxSxFRVNk0f2sV2Z97CY_2jeMi3A2ixFStHPoDO_WQ2X-DRZzq3I6vG5aBcK78ALnIDZw
linkProvider Springer Nature
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1LT9wwEB4hStX20Ad9bUtbVyonajVxXvahQqvdrkDQFQeQuBm_IiGtEroJrfhT_EbGeexSIbhx4OpMlElmPP4cz8wH8I2Z1IrUaepEbGmcGE21NY6qJNKOBXmEIw3ZRDad8uNjcbACl30tjE-r7GNiE6htafw_8h-RD6Qxj3mwffaHetYof7raU2i0brHnLv7hlq36uTtG-24yNvl1ONqhHasANXHAa8qFibVinOtQWSHyLBEacYjJtMiE0jywPOXKWOXi2EVCq0DhGG4rbKBMwH3zJQz5jxBGMN6kCh4sNngIR9qE_iyiKWKZrkinLdVjnjUNV0jqSydSKv5fCG-g2xsns82CN3nx0D7VS3jeQWsybOfCK1hxxTo8bsk2L9bh2bXWi69he1iQaz1GyoKcFnVJRm42o5O5c2Q8HeIQGXcEMjXxpTQoNvLTZF69gaN7eZe3sFqUhXsPxCSG53nCWdZkyVoV5r7pkHbcJYh32ADC3rLSdJ3WPeHHTC57RHtvkOgNsvEGKQawtbjnrO0zcqf0Rm952cWcSi7NPoCvi8sYLfwRkCpceV5JJgImEgT14naZCN04RCCaocy71hkXKnl6gjD1T_jee-dSgdv1_XC3vl_gyc7h7325vzvd-whPGeLGNmNoA1br-bn7BGvmb31azT83843AyX177RUojWFF
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1LT9wwEB4hSqv20AeFdlvaulJ7AovEedmHCq12uyqiWu0BJG7Gr0hIq4RuQiv-Wn9dx3nsUiG4ceDqOMok_jz-HM_MB_CFmdSK1GnqRGxpnBhNtTWOqiTSjgV5hC2N2EQ2nfLTUzFbg799LowPq-x9YuOobWn8P_L9yDvSmMc82M-7sIjZeHJw8Yt6BSl_0trLabQQOXJXf3D7Vn07HONYf2Vs8v149IN2CgPUxAGvKRcm1opxrkNlhcizRGjkJCbTIhNK88DylCtjlYtjFwmtAoVtuMWwgTIB94WY0P0_ynzR8iZscLbc7CE1aYP7s4imyGu6hJ02bY95BTVcLalPo0ip-H9RvMF0b5zSNovf5MVD_mwv4XlHucmwnSOvYM0Vm_C4FeG82oRn10oyvoaDYUGu1R4pC3Je1CUZufmcThbOkfF0iE1k3AnL1MSn2GC3kZ8-i2oLTu7lXbZhvSgL9xaISQzP84SzrImetSrMfTEi7bhLkAexAYT9KEvTVWD3QiBzuaod7ZEhERmyQYYUA9hd3nPR1h-5s_dOjwLZ-aJKriAwgM_Ly-hF_NGQKlx5WUkmAiYSJPvi9j4RQjpEgpphnzctMJcmedmCMPVP2OuRujLgdnvf3W3vJ3iCYJU_D6dH7-EpQzrZBhLtwHq9uHQfYMP8rs-rxcdm6hE4u2_Q_gNLy2oC
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=An+Investigation+into+Cell-Free+DNA+in+Different+Common+Cancers&rft.jtitle=Molecular+biotechnology&rft.au=Nafar%2C+Samira&rft.au=Hosseini%2C+Kamran&rft.au=Shokrgozar%2C+Negin&rft.au=Farahmandi%2C+Amir+Yousef&rft.date=2024-12-01&rft.issn=1073-6085&rft.eissn=1559-0305&rft.volume=66&rft.issue=12&rft.spage=3462&rft.epage=3474&rft_id=info:doi/10.1007%2Fs12033-023-00976-9&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s12033_023_00976_9
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1073-6085&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1073-6085&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1073-6085&client=summon